# Cardinal Health (CAH) Q4 FY2026 earnings

Results filed 2026-08-11 for the quarter ended 2026-06-30. Source page: https://earnings.opennash.com/companies/cah/2026-q4/
Press release and documents: https://www.sec.gov/Archives/edgar/data/721371/000072137126000037/0000721371-26-000037-index.htm
> Summaries and transcripts are machine-generated and can contain errors.

## In brief

Cardinal Health is shifting growth toward specialty physician platforms and higher-margin home, logistics and nuclear businesses while the medical products turnaround gains traction, with a tuck-in acquisition added in fiscal 2027.

Cardinal's pharma distribution business grew on brand and specialty sales from existing customers, and the company renewed its wholesaler contract with Kroger. Its Other businesses (Nuclear and Precision Health Solutions, OptiFreight Logistics and at-Home Solutions) grew across all three units. Medical products revenue fell on lower distribution volumes, while Cardinal Health Brand kept growing.
Management plans to deepen its role supporting community specialty physicians, expand the higher-margin growth businesses, and keep executing the medical products improvement plan. Two tuck-in deals (Strive Medical and AdaptHealth's Diabetes Health business) and a new Indianapolis distribution center support that. The main tension is that medical products profit depends on tariffs and the plan, and drug pricing rules, generic deflation and contract renewals remain risks.

## Key numbers

| Metric | Value | Change | Basis |
| --- | --- | --- | --- |
| Q4 revenue | $63.7 billion | up 6% from the fourth quarter of fiscal year 2025 |  |
| Q4 diluted EPS | $1.70 | up 70% | GAAP |
| Q4 diluted EPS | $2.91 | up 40% | non-GAAP |
| Q4 operating earnings | $729 million | up 70% | GAAP |
| Q4 non-GAAP operating earnings | $935 million | up 30% | non-GAAP |
| Q4 net earnings attributable to Cardinal Health | $398 | 67% from a year ago | GAAP |
| Fiscal 2026 operating cash flow | $5.2 billion |  | GAAP |
| Fiscal 2026 adjusted free cash flow | $5.0 billion |  | non-GAAP |

## Segments and operating metrics

| Name | Value | Change |
| --- | --- | --- |
| Pharmaceutical and Specialty Solutions revenue | $58.8 billion | up 6% |
| Pharmaceutical and Specialty Solutions segment profit | $645 million | up 21% |
| Global Medical Products and Distribution revenue | $3.1 billion | down 2% |
| Global Medical Products and Distribution segment profit | $150 million | N.M. |
| Other revenue | $1.7 billion | up 7% |
| Other segment profit | $183 million | up 14% |

## Outlook

| Metric | Period | Outlook |
| --- | --- | --- |
| Non-GAAP diluted EPS | fiscal year 2027 | $12.40 to $12.60 |
| Pharmaceutical and Specialty Solutions revenue growth | fiscal year 2027 | 3% to 5% growth |
| Pharmaceutical and Specialty Solutions segment profit growth | fiscal year 2027 | 8% to 11% growth |
| Global Medical Products and Distribution revenue growth | fiscal year 2027 | 2% to 4% growth |
| Global Medical Products and Distribution segment profit | fiscal year 2027 | $200 million to $220 million |
| Other segment revenue growth | fiscal year 2027 | 11% to 13% growth |
| Other segment profit growth | fiscal year 2027 | 15% to 18% growth |
| Non-GAAP effective tax rate | fiscal year 2027 | 19.0% to 20.0% |
| Capital expenditures | fiscal year 2027 | ~$700 million |
| Non-GAAP adjusted free cash flow | fiscal year 2027 | $3.5 billion to $4.0 billion |

## Key takeaways

1. **Specialty physician platforms anchor pharma growth strategy** Cardinal is positioning itself to support community-based physicians through MSO platforms, data and technology, scaled contracting and specialty distribution. Recent practice acquisitions (Integrated Oncology Network, GI Alliance, Urology America, Solaris Health) deepen this model.
2. **Higher-margin Other businesses are the growth engine** Nuclear and Precision Health Solutions, OptiFreight Logistics and at-Home Solutions grew across all three units, and management expects 11% to 13% revenue growth next year. Cardinal is investing in PET and Theranostics capacity and launched an outbound pharmacy shipping solution.
3. **Two tuck-in acquisitions extend home-care footprint** Cardinal completed the Strive Medical acquisition and announced the Diabetes Health business of AdaptHealth, both reflected in fiscal 2027 guidance. They build on care shifting to more cost-effective, comfortable settings.
4. **Medical products turnaround is progressing, tariff-dependent** U.S. Cardinal Health Brand revenue grew at least mid single digits for six consecutive quarters, with simplified manufacturing and more domestic production. Even so, quarterly segment profit excluding IEEPA refunds fell from $70 million to $50 million.
5. **Kroger renewal and new automated center add capacity** Cardinal announced a long-term renewal of its wholesaler distribution contract with Kroger. A new Indianapolis distribution center with advanced robotics and automation is set to open in 2027.

## Questions

**What is Cardinal Health's main strategic focus for fiscal 2027?** Its priorities are simplification, expanding in specialty within Pharmaceutical and Specialty Solutions, executing the GMPD Improvement Plan, and accelerating the higher-margin Other businesses.
**How is Cardinal supporting community physicians?** It offers MSO platforms in oncology and other specialties, data and technology solutions such as analytics and real-world evidence, plus broad distribution, scaled contracting and GPO offerings.
**Which acquisitions does Cardinal's fiscal 2027 outlook include?** The outlook reflects the completed tuck-in acquisition of Strive Medical and the announced tuck-in acquisition of the Diabetes Health business of AdaptHealth.
**How is the medical products business doing?** Cardinal Health Brand U.S. revenue grew at least mid single digits for six consecutive quarters, but distribution volumes fell and quarterly segment profit excluding tariff refunds declined.
**What capacity investments is Cardinal making?** It plans about $700 million of capital spending covering automation, new distribution centers, nuclear capacity and MSO platform technology, including an Indianapolis distribution center opening in 2027.

## Slides and investor documents

- [Presentation](https://s201.q4cdn.com/566741227/files/doc_financials/2026/q4/Q4-FY26-Earnings-Presentation-FINAL.pdf) (Slide deck)
- [Transcript](https://s201.q4cdn.com/566741227/files/doc_financials/2026/q4/Q4-FY26-CAH-Earnings-Transcript.pdf) (Company's official transcript)
- [Webcast](https://events.q4inc.com/attendee/702473644) (Webcast replay)
- [Form 10-K](https://s201.q4cdn.com/566741227/files/doc_financials/2026/q4/10-K.pdf) (Document)

